| Literature DB >> 3152917 |
J de Kraker1, J Pritchard, O Hartmann, J Ninane.
Abstract
Twenty-five patients with progressive or recurrent neuroblastoma were treated with single-agent ifosfamide. In 2 of 10 relapsing patients, an objective response was observed. If ifosfamide is administered in a dose of 3000 mg/m2 for 2 days every 3 weeks, a response can be expected in 8% of the cases.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3152917 DOI： 10.3109/08880018709141255
Source DB: PubMed Journal: Pediatr Hematol Oncol ISSN： 0888-0018 Impact factor: 1.969